UNSPSC 85771904: Revision of autologous tissue substitute in left upper extremity, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in left upper extremity, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0XW737Z

UNSPSC 85771904 Revision of autologous tissue substitute in left upper extremity, percutaneous approach is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally addresses a specific orthopedic surgical procedure, yet the recent opportunities posted under this code span independent medical evaluation services for pension disability determinations, occupational health surveillance, surgical benefit carve-outs for municipal employees, pharmacy benefit management, temporary health professional staffing, and emergency medical services for detained youth. None of these procurements involve autologous tissue revision or percutaneous orthopedic repair. The issuing bodies include city retirement boards, county human resources divisions, state transportation departments, county health systems, and juvenile justice agencies—a wide range of public health and benefits administration functions rather than surgical procedure providers or orthopedic specialists.

Recent opportunities posted under this code include the City of Phoenix Retirement Office requesting independent medical evaluation services (RFP RTMRFP26001, due October 16, 2026, $750,000 over five years), the Washington State Department of Transportation soliciting occupational medical surveillance for ferry workers (RFP RFP20260825, due October 9, 2026), and the County of Santa Clara Health System establishing a qualified vendor pool for temporary health professional staffing across multiple ancillary clinical categories (RFSQHHSFY270052, due October 7, 2026). The geographic spread includes Arizona, Washington, California, Florida, and Texas. The code appears to have been applied inconsistently or incorrectly to these health benefits and occupational health opportunities, with no evidence of recent procurement specifically targeting autologous tissue revision procedures or orthopedic surgical services in state and local markets. Firms pursuing this code should verify tagging accuracy with issuing bodies before bidding, as the code's nominal scope and actual posted opportunities are substantially misaligned.